CTCX Stock Overview
Operates as a bio-aesthetics company. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Carmell Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.49 |
| 52 Week High | US$4.00 |
| 52 Week Low | US$0.20 |
| Beta | 0.29 |
| 1 Month Change | 134.44% |
| 3 Month Change | 41.64% |
| 1 Year Change | -86.01% |
| 3 Year Change | -94.90% |
| 5 Year Change | n/a |
| Change since IPO | -94.95% |
Recent News & Updates
Shareholder Returns
| CTCX | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -20.2% | -2.1% | -2.1% |
| 1Y | -86.0% | -8.3% | 21.3% |
Return vs Industry: CTCX underperformed the US Biotechs industry which returned -8.3% over the past year.
Return vs Market: CTCX underperformed the US Market which returned 21.3% over the past year.
Price Volatility
| CTCX volatility | |
|---|---|
| CTCX Average Weekly Movement | 52.8% |
| Biotechs Industry Average Movement | 11.2% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 18.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: CTCX's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CTCX's weekly volatility has increased from 31% to 53% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 10 | Kendra Bracken-Ferguson | www.carmellcosmetics.com |
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks.
Carmell Corporation Fundamentals Summary
| CTCX fundamental statistics | |
|---|---|
| Market cap | US$10.29m |
| Earnings (TTM) | -US$9.75m |
| Revenue (TTM) | US$32.84k |
313.4x
P/S Ratio-1.1x
P/E RatioIs CTCX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CTCX income statement (TTM) | |
|---|---|
| Revenue | US$32.84k |
| Cost of Revenue | US$5.13k |
| Gross Profit | US$27.71k |
| Other Expenses | US$9.77m |
| Earnings | -US$9.75m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.47 |
| Gross Margin | 84.37% |
| Net Profit Margin | -29,675.45% |
| Debt/Equity Ratio | -8.9% |
How did CTCX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/12 10:43 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Carmell Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|